ArticleAmerican journal of respiratory and critical care medicine2023
Sustained Improvement of Cystic Fibrosis Lung Disease following Initiation of Elexacaftor/Tezacaftor/Ivacaftor Therapy: Lessons from Real-World Studies.
Eva Steinke et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.